(Q39447029)

English

Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

A M Namboodiri

1

1 reference

Europe PubMed Central

12 September 2017

J P Pandey

2

1 reference

Europe PubMed Central

12 September 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

12 September 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

12 September 2017

166

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

361-365

1 reference

Europe PubMed Central

12 September 2017

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Engineered antibody Fc variants with enhanced effector function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Monoclonal antibodies: versatile platforms for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Toward a genetics of cancer resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of whole blood antibody dependent cellular cytotoxicity by heat aggregated human IgG

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2011.04477.X

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39447029&oldid=1828588873"